UNSPSC 51334205: Zotepine

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C18H18ClNOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U29O83JAZW, chemically known as 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo(b,f)thiepine but generally known as zotepine, which bears US NIH Compound Identifier 5736. European Medicines Agency schedules Zotepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00191MIG.

UNSPSC 51334205 Zotepine is a Commodity code that in recent state and local procurement covers the purchase of pharmaceutical products and related medical supplies, though the tagged recent opportunity reflects a significant mismatch with the code's nominal scope. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems rather than Zotepine itself, suggesting that state and local jurisdictions may be using this code to tag a broader class of emergency pharmaceutical and harm-reduction supplies. The work involves sourcing finished pharmaceutical products for direct delivery to health departments or community health facilities on a recurring basis, with vendors responsible for fulfilling quarterly or annual delivery schedules, maintaining insurance and compliance certifications (drug-free workplace, E-Verify), and submitting unit-cost bids through electronic procurement portals.

Seminole County, Florida represents the only recent activity visible under this code. The IFB posted June 30, 2026 (with a due date of July 26, 2023, reflecting a data-entry error in the source) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for delivery to the Seminole County Community Health Building in Sanford, with a fixed-fee contract structure, an initial two-year term, and a one-year renewal option. The procurement included a three-month probationary termination period and potential FEMA funding with attendant federal environmental compliance requirements. No explicit small-business, minority-owned, or disadvantaged-enterprise set-asides were noted. The code shows limited recent state and local solicitation activity; the single opportunity does not align clearly with Zotepine acquisition, suggesting the code may be infrequently or misapplied in state and local procurement.